Literature DB >> 12390051

Restless legs syndrome in the older adult: diagnosis and management.

Shawn A Milligan1, Andrew L Chesson.   

Abstract

Restless legs syndrome (RLS) is common in the elderly, with an estimated prevalence of 10 to 35% in individuals over 65 years of age. RLS is characterised by paraesthesias and dysaesthesias of the legs, typically occurring in the evening. The symptoms occur at rest and result in motor restlessness; movement often temporarily relieves the symptoms. Patients with poorly controlled RLS may develop related problems including insomnia (due to sleep-onset restlessness or periodic limb movements or related sleep fragmentation) and depression. RLS can be a primary disorder that develops in the young and includes familial cases. Secondary RLS occurs in association with iron-deficiency anaemia, uraemia and polyneuropathies. Typically, RLS is misdiagnosed or undiagnosed for years. In the elderly, both primary and secondary types of the disorder are common. It is thought that RLS represents lower CNS levels of, or reduced responsiveness to, dopamine. The symptoms improve with dopaminergic therapy. Ergotamine dopamine-receptor agonists such as pergolide, and the non-ergotamine dopamine-receptor agonists pramipexole and ropinirole, are becoming more commonly used to treat RLS. The dopamine precursor levodopa, in combination with carbidopa, is another effective therapeutic agent. An advantage of levodopa is lower cost than non-ergotamine and ergotamine dopamine-receptor agonists. However, the adverse effect of symptom augmentation appears to develop more frequently with levodopa than dopamine-receptor agonists; therefore, levodopa may currently be used somewhat less often as first-line therapy. Patients with painful symptoms may respond favourably to the anticonvulsants gabapentin and carbamazepine. Opioids and hypnosedatives are helpful in selected patients; however, these agents may have troubling adverse effects in the elderly. Correction of iron deficiency improves symptoms in patients with low ferritin levels. Lifestyle modification may also be helpful. Therapy is directed at symptoms, and most symptomatic patients benefit from treatment. It is important to consider RLS in the differential diagnosis of any patient with paraesthesias of the limbs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390051     DOI: 10.2165/00002512-200219100-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  31 in total

Review 1.  Waking up to sleep episodes in Parkinson's disease.

Authors:  C W Olanow; A H Schapira; T Roth
Journal:  Mov Disord       Date:  2000-03       Impact factor: 10.338

2.  A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients.

Authors:  M L Thorp; C D Morris; S P Bagby
Journal:  Am J Kidney Dis       Date:  2001-07       Impact factor: 8.860

3.  Validation of the Johns Hopkins restless legs severity scale.

Authors:  R P. Allen; C J. Earley
Journal:  Sleep Med       Date:  2001-05       Impact factor: 3.492

4.  A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome.

Authors:  B J Davis; A Rajput; M L Rajput; E A Aul; G R Eichhorn
Journal:  Eur Neurol       Date:  2000       Impact factor: 1.710

5.  Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset.

Authors: 
Journal:  Sleep Med       Date:  2000-02-01       Impact factor: 3.492

6.  Pramipexole in the treatment of restless legs syndrome: a follow-up study.

Authors:  J Montplaisir; R Denesle; D Petit
Journal:  Eur J Neurol       Date:  2000-05       Impact factor: 6.089

Review 7.  Newer dopamine agonists in the treatment of restless legs syndrome.

Authors:  P R Weimerskirch; M E Ernst
Journal:  Ann Pharmacother       Date:  2001-05       Impact factor: 3.154

8.  Iron status and restless legs syndrome in the elderly.

Authors:  S T O'Keeffe; K Gavin; J N Lavan
Journal:  Age Ageing       Date:  1994-05       Impact factor: 10.668

Review 9.  Restless legs syndrome. A review.

Authors:  S T O'Keeffe
Journal:  Arch Intern Med       Date:  1996-02-12

10.  Iron and the restless legs syndrome.

Authors:  E R Sun; C A Chen; G Ho; C J Earley; R P Allen
Journal:  Sleep       Date:  1998-06-15       Impact factor: 5.849

View more
  14 in total

1.  The burden of restless legs syndrome: an assessment of work productivity, sleep, psychological distress, and health status among diagnosed and undiagnosed individuals in an internet-based panel.

Authors:  Sheri Fehnel; Laurie Zografos; Tammy Curtice; Hemal Shah; Lori McLeod
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

2.  Burden of restless legs syndrome on health-related quality of life.

Authors:  Clete Kushida; Marie Martin; Prashant Nikam; Bonnie Blaisdell; Gene Wallenstein; Luigi Ferini-Strambi; John E Ware
Journal:  Qual Life Res       Date:  2007-02-01       Impact factor: 4.147

Review 3.  Ropinirole: for the treatment of restless legs syndrome.

Authors:  Susan M Cheer; Lynne M Bang; Gillian M Keating
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Sleep disturbances in caregivers of persons with dementia: contributing factors and treatment implications.

Authors:  Susan M McCurry; Rebecca G Logsdon; Linda Teri; Michael V Vitiello
Journal:  Sleep Med Rev       Date:  2007-02-06       Impact factor: 11.609

Review 5.  Sleep and aging: 2. Management of sleep disorders in older people.

Authors:  Norman Wolkove; Osama Elkholy; Marc Baltzan; Mark Palayew
Journal:  CMAJ       Date:  2007-05-08       Impact factor: 8.262

Review 6.  Sleep and aging: 1. Sleep disorders commonly found in older people.

Authors:  Norman Wolkove; Osama Elkholy; Marc Baltzan; Mark Palayew
Journal:  CMAJ       Date:  2007-04-24       Impact factor: 8.262

7.  Insomnia In Caregivers Of Persons With Dementia: Who Is At Risk And What Can Be Done About It?

Authors:  Susan M McCurry; Laura E Gibbons; Rebecca G Logsdon; Michael V Vitiello; Linda Teri
Journal:  Sleep Med Clin       Date:  2009-12-01

8.  Polymorphisms of interleukin-1 Beta and interleukin-17Alpha genes are associated with restless legs syndrome.

Authors:  Mary Dawn Hennessy; Rochelle S Zak; Caryl L Gay; Clive R Pullinger; Kathryn A Lee; Bradley E Aouizerat
Journal:  Biol Res Nurs       Date:  2013-03-03       Impact factor: 2.522

9.  Effects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trial.

Authors:  Kim E Innes; Terry Kit Selfe; Caitlin Montgomery; Nicole Hollingshead; Zenzi Huysmans; Roshini Srinivasan; Sijin Wen; Madeleine J Hausmann; Karen Sherman; Maryanna Klatt
Journal:  J Clin Sleep Med       Date:  2020-01-15       Impact factor: 4.062

10.  The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial.

Authors:  Kim E Innes; Terry Kit Selfe
Journal:  Evid Based Complement Alternat Med       Date:  2012-01-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.